The immunophenoscores of ccRCC patients from TCIA database (https://tcia.at/) were also utilized to assess the immune properties of ADAMTS14 in ccRCC and the low- and high-ADAMTS14 groups had different immunogenicity for CTLA4 immunotherapy. Here, CTLA4 is linked to nonpapillary renal cell carcinoma.